Jefferies published a note on Integra LifeSciences Holdings IART today after the company's long-time CEO Stuart Essig stepped down. COO Peter Arduini will take his place. Jefferies has a Buy rating and $43 price target for Integra LifeSciences.
In the report, Jefferies stated, "Stuart Essig has been the chief architect of the acquisition-driven strategy that has served Integra well over the past 14 years. His departure likely represents a new chapter for the company, one more reliant on value creation through 'operating well' rather than through acquisition."
Shares of Integra LifeSciences Holdings closed at $31.19 today, down 0.22% from Tuesday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in